Loading...
Scholar Rock Holding Corp (SRRK) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong analyst ratings, reduced manufacturing risks, recent insider purchases, and solid cash reserves make it a promising investment opportunity. While technical indicators are mixed, the long-term growth potential outweighs short-term fluctuations.
The stock's MACD is negative (-0.237) and expanding downward, indicating bearish momentum. RSI is neutral at 28.248, suggesting no clear overbought or oversold condition. However, moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 44.856, and resistance is at 48.32. The pre-market price of 44.74 is close to the support level, offering a potential entry point.

and consistent Buy ratings.
In Q3 2025, the company reported no revenue growth (0% YoY), but net income improved significantly (-102.22M, up 58.53% YoY). EPS also improved to -0.9, up 36.36% YoY. The company has a strong cash position of $365M, providing a buffer for future growth.
Analysts are highly optimistic about SRRK, with multiple Buy ratings and increased price targets ranging from $52 to $60. Analysts cite reduced manufacturing risks, a de-risked launch trajectory for apitegromab, and strong biotech fundamentals as reasons for their confidence.